Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
Genes & Development
Katz, Chen C; Low-Calle, Ana Maria AM; Choe, Joshua H JH; Laptenko, Oleg O; Tong, David D; Joseph-Chowdhury, Jazmine-Saskya N JN; Garofalo, Francesca F; Zhu, Yan Y; Friedler, Assaf A; Prives, Carol C
Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma.
Nature Medicine
Mai, Wilson X WX; Gosa, Laura L; Daniels, Veerle W VW; Ta, Lisa L; Tsang, Jonathan E JE; Higgins, Brian B; Gilmore, W Blake WB; Bayley, Nicholas A NA; Harati, Mitra Dehghan MD; Lee, Jason T JT; Yong, William H WH; Kornblum, Harley I HI; Bensinger, Steven J SJ; Mischel, Paul S PS; Rao, P Nagesh PN; Clark, Peter M PM; Cloughesy, Timothy F TF; Letai, Anthony A; Nathanson, David A DA